Cargando…

Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey

The BOADICEA breast cancer (BC) risk assessment model and its associated Web Application v3 (BWA) tool are being extended to incorporate additional genetic and non-genetic BC risk factors. From an online survey through the BOADICEA website and UK, Dutch, French and Swedish national genetic societies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brédart, Anne, Kop, Jean-Luc, Antoniou, Antonis C., Cunningham, Alex P., De Pauw, Antoine, Tischkowitz, Marc, Ehrencrona, Hans, Schmidt, Marjanka K., Dolbeault, Sylvie, Rhiem, Kerstin, Easton, Douglas F., Devilee, Peter, Stoppa-Lyonnet, Dominique, Schmutlzer, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325038/ https://www.ncbi.nlm.nih.gov/pubmed/29508368 http://dx.doi.org/10.1007/s12687-018-0362-8

Ejemplares similares

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
por: Brédart, Anne, et al.
Publicado: (2017)

Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study
por: Brédart, Anne, et al.
Publicado: (2022)

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study
por: Brédart, Anne, et al.
Publicado: (2022)

Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant
por: Brédart, Anne, et al.
Publicado: (2021)

Patient-Centered Care in Breast Cancer Genetic Clinics
por: Brédart, Anne, et al.
Publicado: (2018)

Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer
por: Brédart, A, et al.
Publicado: (2013)

Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study
por: Brédart, Anne, et al.
Publicado: (2019)

Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study
por: Archer, Stephanie, et al.
Publicado: (2020)

Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model
por: Lee, Andrew J., et al.
Publicado: (2016)

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis
por: Allen, Isaac, et al.
Publicado: (2023)

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence
por: Lee, Andrew, et al.
Publicado: (2022)

Incorporating tumour pathology information into breast cancer risk prediction algorithms
por: Mavaddat, Nasim, et al.
Publicado: (2010)

Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis
por: Allen, Isaac, et al.
Publicado: (2022)

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
por: Lakeman, Inge M. M., et al.
Publicado: (2020)

Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
por: van Barele, Mark, et al.
Publicado: (2023)

Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons
por: Pages, S, et al.
Publicado: (2001)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
por: Mavaddat, Nasim, et al.
Publicado: (2023)

Potential of polygenic risk scores for improving population estimates of women’s breast cancer genetic risks
por: Wolfson, Michael, et al.
Publicado: (2021)

BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis
por: Nyberg, Tommy, et al.
Publicado: (2021)

Proactive breast cancer risk assessment in primary care: a review based on the principles of screening
por: Usher-Smith, Juliet A., et al.
Publicado: (2023)

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction
por: Giardiello, Daniele, et al.
Publicado: (2020)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study
por: Yang, Xin, et al.
Publicado: (2022)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Familial risks of breast cancer
por: Easton, Douglas F
Publicado: (2002)

Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?
por: d'Almeida, A K, et al.
Publicado: (2005)

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families
por: Janin, N, et al.
Publicado: (1999)

Gene–environment interaction and risk of breast cancer
por: Rudolph, Anja, et al.
Publicado: (2016)

Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium
por: Kapoor, Pooja Middha, et al.
Publicado: (2020)

Risk Estimation as a Decision-Making Tool for Genetic Analysis of the Breast Cancer Susceptibility Genes
por: Chang-Claude, Jenny, et al.
Publicado: (1999)

Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?
por: Pashayan, Nora, et al.
Publicado: (2021)

Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
por: Mavaddat, Nasim, et al.
Publicado: (2010)

Personalized early detection and prevention of breast cancer: ENVISION consensus statement
por: Pashayan, Nora, et al.
Publicado: (2020)

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
por: Escala-Garcia, Maria, et al.
Publicado: (2020)

Australian clinicians and chemoprevention for women at high familial risk for breast cancer
por: Keogh, Louise A, et al.
Publicado: (2009)

Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe
por: Morrison, P. J., et al.
Publicado: (1999)

Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic
por: Saghatchian, Mahasti, et al.
Publicado: (2022)

Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK
por: Antoniou, A C, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_h0iphuva00nqar7tniv4usa694